Investor Ideas #Potcasts
538, #Cannabis News and #Stocks on the Move; (TSX: $VLNS.TO) (TSX: $CWEB.TO)
(CSE: $PULL.C) (OTC: $MJNA) (CSE: $IPOT.C)
Delta, Kelowna, BC, March 3, 2021(Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/030321-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/03031VLNS-CWEB-PULL-MJNA-IPOT.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
The
Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF), a leading manufacturer of
cannabis products, today announced that it has entered into an
extraction and custom manufacturing agreement with Rubicon Organics, a Canadian
licensed producer of high-quality, organic certified, sustainably grown
cannabis. Rubicon Organics boasts a robust portfolio of recreational brands
that meet the diversified needs of consumers, including super-premium Simply
Bare Organic, flower-based 1964 Supply Co., in addition to concentrate-focused
Lab Theory.
Under the terms of the agreement,
Valens will have the opportunity to leverage its full complement of proprietary
extraction capabilities, including organic certified CO2, ethanol, and other
extraction technologies, to deliver customized consumer experiences in a
variety of 2.0 products under the Rubicon Organics portfolio. Additionally, the
custom manufacturing agreement provides a platform for collaboration, new
product development and innovation to bring next generation formats to the
market, allowing Valens to further expand its industry-leading portfolio of
product manufacturing capabilities.
"The Rubicon Organics team has
a strong and proven track record of success with their flower business and we
are confident they will enjoy the same success in other product
categories," said Tyler Robson, Chief Executive Officer, Co-Founder and
Chair of The Valens Company. "At the heart of this agreement is a true
partnership and both parties are eager to get down to work on innovation to
bolster Rubicon Organics' product portfolio and bring certified organic,
high-quality 2.0 products to the Canadian market. We are especially pleased to
be working with a supply partner that can meet our strict requirements for
laboratory controls, quality and reliability."
"This agreement will enable
Rubicon Organics to accelerate the launch of our organic certified 2.0
innovation pipeline, providing our consumers with the best cannabis products in
Canada, and growing our share of the premium and super premium cannabis
category," said Jesse McConnell, Chief Executive Officer of Rubicon
Organics.
Charlotte's
Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), the market leader in
full-spectrum hemp CBD extract products, announced that it has entered into an Option
Purchase Agreement with Stanley Brothers USA Holdings, Inc., a privately-held
Delaware company, and the shareholders of Stanley Brothers USA. Stanley
Brothers USA is a cannabis wellness incubator currently operating in three
states (Colorado, California, Florida) with expansion plans underway in eight
additional states. The Option has a five-year term (extendable for an
additional two years) and provides Charlotte's Web the optionality to acquire
Stanley Brothers USA on the earlier of three years from the effective date of
the Option and federal legalization of cannabis in the United States, or such
earlier time as Stanley Brothers USA and Charlotte's Web may agree potentially
including when otherwise permitted by the policies of the stock exchange on
which the Company's securities are listed for trading. The common shares of
Charlotte's Web continue to trade on the TSX in Canada and OTCQX in the US.
"Consumer attitudes, market
trends, and laws surrounding cannabis and its role within the wellness category
continue to trend positively. This strategic Option provides Charlotte's Web
optionality to enter the U.S. cannabis wellness market in partnership with an
experienced and trusted team and brand, positioning our business for potential
new growth opportunities and shareholder value creation," explained Deanie
Elsner, CEO of Charlotte's Web. "The Stanley Brothers are innovating
cannabis wellness with the same philosophy and vision that drove their success
as founders of the Charlotte's Web brand. With this shared heritage, we could
not be more aligned."
Stanley Brothers USA is evolving
botanical formulations for the Cannabis 2.0 wellness-focused consumer,
combining full-spectrum cannabis extracts with functional botanical
ingredients. Marketed under the "ReCreate" brand, the wellness
formulations are lower in tetrahydrocannabinol ("THC") for more precisely controllable benefits. Products
include functional chocolates, gummies and oil tinctures, formulated with the
wellness benefits of the entire cannabis plant including CBD and THC to help
achieve a desired state of wellbeing.
Charlotte's Web is the global leader
in the cultivation, production and distribution of hemp-derived CBD wellness
products. Until the Option is exercised, both Charlotte's Web and Stanley
Brothers USA will continue to operate as standalone entities in the US.
Internationally the companies are able to explore opportunities where cannabis
is federally permissible.
Pure
Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF), a plant-based extraction company
focused on cannabis, hemp, functional mushrooms and the rapidly emerging
psychedelic sector, announced that its wholly owned subsidiary,
Pure Extracts Manufacturing Corp., has ordered in excess of 30,000 vape
cartridges and vape pens for the Canadian market.
These vape products are produced by
a global manufacturer and adhere to the highest North American standards and
are expected to arrive at the Company’s British Columbia facility in the first
week of April. These products were specifically chosen for the quality of their
component parts, their fit and finish and their performance characteristics
when paired with Pure Extracts’ oil concentrates. This timing coincides with
Pure Extracts’ ramp-up for its recently announced retail distribution agreement
and its submission of over 20 product SKUs to Health Canada for approval. The
cartridges will be filled with a selection of some of the Company’s 30+
proprietary, full spectrum oil (FSO), formulations.
Demand for these types of
concentrates is strong in the 4 provinces (British Columbia, Alberta,
Saskatchewan and Ontario) that the Company is targeting for its retail launch
and revenue estimates for this shipment are approximately $650,000.
Pure Extracts CEO, Ben Nikolaevsky,
remarked, “We are looking forward to building our vape pen inventory in
preparation for our retail launch through established provincial distribution
channels. At the same time, we plan to launch our Pure Chews brand of CBD and
THC edible gummie products and we have been steadily accumulating all the
components from the oil extracts to the flavouring to our proprietary
packages.”
Medical
Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded
cannabis company in the United States that launched the world’s first-ever
cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of
its subsidiary Kannaway® had its best sales month ever in Company history in
February 2021.
“When we first entered the Japanese
market in late 2019, we were one of the first companies offering cannabidiol
(CBD) products in the country and saw a great opportunity to give consumers the
high-quality products they had been asking for,” said Kannaway® CEO Blake
Schroeder. “Since then, our team has done tremendous work expanding our reach
and footprint in Japan.”
The Japanese CBD market looks to
continue rapidly expanding in the coming years. According to Research and
Markets, the global CBD oil market is expected to reach $5.3 billion by 2025
with Asia-Pacific as one of the fastest-growing regions.
“While leading our team in Japan, I
have seen the positive response to our offerings in the country first-hand. Our
team has shown what can be done with hard work and a distinguishing product
offering and I look forward to our further growth,” said Kannaway® Japan
Division General Manager Peter Dale.
Isracann
Biosciences Inc. (CSE: IPOT) (OTC: ISCNF) an Israel-based company focused on
becoming a premier low cost, high quality cannabis producer/distributor announced that it has entered a non-binding Letter
of Intent (LOI) outlining an importation sales agreement with a major Israeli
medical cannabis company.
The proposed relationship is with
one of the leading cannabis product manufacturers in Israel, who for commercial
reasons can not be identified at this time. Imported goods will consist of
premium Canadian cannabis via Isracann’s agreement with Costa Canna Group’s
cultivation subsidiary, United Greeneries Ltd. The arrangement includes the
provision that all imported material will be sold under the Isracann brand with
subsequent products locally manufactured by the proposed partner in accordance
with Israeli GMP requirements.
Isracann’s Canadian import/export
agreement provides exclusive access to established specialty strains including
ultra high THC, high CBD, balanced, and specialty craft-grown strains which
will eventually serve as alternative product offerings concurrent to the introduction
of its own premium Israeli grown and branded products upon the commencement of
cultivation from local Isracann-owned farm facilities.
The importance of imported sales
through Isracann include immediate revenue generation, introduction of new brands
to the Israeli market, and the ability to trial Isracann’s processing
facilities and domestic distribution arrangements. The need to identify new
logistics, systems and business opportunities prior to the anticipated
explosive growth potential posed by recent recreational legalization efforts
and pending access to major European markets are considered critical strategic
factors for the sustainable growth of the Company.
The Israeli market for medical
cannabis continues to grow at a rapid pace. Now with over 80,000 medical
patients (IMCA data), the domestic
growers are struggling to keep up with demand. Recent news regarding
recreational legalization efforts position the local industry to grow to an
indicated 2.5 million potential consumers.
Company CEO Darryl Jones states,
“The agreement in-place is straightforward and is a win-win for both parties.
The inexorable growth in demand for medical cannabis products combined with the
potential recreational and export market scenarios means that the serious operators
are making decisions right now as to how they will manage demand stressors in
future. We have been speaking with several of the larger players in the sector
and todays announcement is likely to be joined with some additionally positive
commercial decisions in the coming months. All of which means that we appear to
be in the right place at the right time. Our team in Israel are well-connected
and ensuring we are aware of the numerous opportunities and prevailing trends
that allow us to act proactively. Strategically, we remain focused on securing
agreements and opportunities in order to firmly position Isracann where we can
best grow our value proposition and capitalize on the unfolding events in this
exciting region.”
Investor ideas reminds all listeners
to read our disclaimers and disclosures on the Investorideas.com website and
that this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can trade these stocks and other ideas on our site using our list of
top stock trading apps including
Robinhood , Acorn, Stash and others.
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on
iTunes ( Apple Podcasts) , Audible ,
Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Play Music and most audio platforms
available.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
No comments:
Post a Comment